These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34174518)

  • 1. Radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy with or without chemotherapy: Development of a nomogram based on the equivalent dose.
    Zhu MY; Wu HJ; Miao JJ; Di MP; Chen BY; Huang HG; Mai HQ; Wang L; Zhao C
    Oral Oncol; 2021 Sep; 120():105378. PubMed ID: 34174518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram for radiation-induced hypothyroidism prediction in nasopharyngeal carcinoma after treatment.
    Luo R; Li M; Yang Z; Zhan Y; Huang B; Lu J; Xu Z; Lin Z
    Br J Radiol; 2017 Feb; 90(1070):20160686. PubMed ID: 27885853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposal of a Pretreatment Nomogram for Predicting Local Recurrence after Intensity-Modulated Radiation Therapy in T4 Nasopharyngeal Carcinoma: A Retrospective Review of 415 Chinese Patients.
    Zhang LL; Li YY; Hu J; Zhou GQ; Chen L; Li WF; Lin AH; Ma J; Qi ZY; Sun Y
    Cancer Res Treat; 2018 Oct; 50(4):1084-1095. PubMed ID: 29141396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study.
    Huang CL; Tan HW; Guo R; Zhang Y; Peng H; Peng L; Lin AH; Mao YP; Sun Y; Ma J; Tang LL
    Cancer Med; 2019 Nov; 8(16):6887-6893. PubMed ID: 31560840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma.
    Sommat K; Ong WS; Hussain A; Soong YL; Tan T; Wee J; Fong KW
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):574-580. PubMed ID: 28581397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era.
    Yang K; Xie W; Zhang X; Wang Y; Shou A; Wang Q; Tian J; Yang J; Li G
    Aging (Albany NY); 2021 Jul; 13(14):18645-18657. PubMed ID: 34282056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multivariable normal tissue complication probability model for predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients in the modern radiotherapy era.
    Wongwattananard S; Prayongrat A; Srimaneekarn N; Hayter A; Sophonphan J; Kiatsupaibul S; Veerabulyarith P; Rakvongthai Y; Ritlumlert N; Kitpanit S; Kannarunimit D; Lertbutsayanukul C; Chakkabat C
    J Radiat Res; 2024 Jan; 65(1):119-126. PubMed ID: 37996086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial.
    Lertbutsayanukul C; Kitpanit S; Prayongrat A; Kannarunimit D; Netsawang B; Chakkabat C
    J Radiat Res; 2018 Jul; 59(4):446-455. PubMed ID: 29750261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.
    Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y
    Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy.
    Zhai R; Lyu Y; Ni M; Kong F; Du C; Hu C; Ying H
    Radiat Oncol; 2022 Mar; 17(1):57. PubMed ID: 35313921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-induced nasopharyngeal ulcers after intensity modulated radiotherapy in primary nasopharyngeal carcinoma patients: A dose-volume-outcome analysis.
    Li Y; Xu T; Qian W; Lu X; Hu C
    Oral Oncol; 2018 Sep; 84():1-6. PubMed ID: 30115466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.
    Luo R; Wu VWC; He B; Gao X; Xu Z; Wang D; Yang Z; Li M; Lin Z
    BMC Cancer; 2018 May; 18(1):575. PubMed ID: 29776390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
    Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
    Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.
    Wu S; Xia B; Han F; Xie R; Song T; Lu L; Yu W; Deng X; He Q; Zhao C; Xie C
    PLoS One; 2015; 10(8):e0134491. PubMed ID: 26248338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma.
    Lee V; Chan SY; Choi CW; Kwong D; Lam KO; Tong CC; Sze CK; Ng S; Leung TW; Lee A
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e52-60. PubMed ID: 27235379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Nomogram for Severe Oral Mucositis in Patients with Nasopharyngeal Carcinoma during Intensity-Modulated Radiation Therapy: A Retrospective Cohort Study.
    Liu Z; Huang L; Wang H; Shi Z; Huang Y; Liang L; Wang R; Hu K
    Curr Oncol; 2022 Dec; 30(1):219-232. PubMed ID: 36661666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid V40 is a good predictor for subclinical hypothyroidism in patients with nasopharyngeal carcinoma after intensity modulated radiation therapy: a randomized clinical trial.
    Xu Y; Peng H; Su G; Cheng Y; Guo Q; Guo L; Peng XE; Ke J
    Radiat Oncol; 2023 Aug; 18(1):141. PubMed ID: 37626342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid V
    Zhou L; Chen J; Shen W; Chen ZL; Huang S; Tao CJ; Chen M; Yu ZH; Chen YY
    Radiat Oncol; 2020 Mar; 15(1):68. PubMed ID: 32293496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic nomogram to predict the distant metastasis after intensity-modulated radiation therapy for patients with nasopharyngeal carcinoma.
    Mi JL; Xu M; Liu C; Wang RS
    Medicine (Baltimore); 2021 Nov; 100(47):e27947. PubMed ID: 34964774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-induced nasopharyngeal ulcers after re-irradiation with intensity-modulated radiotherapy in locoregional recurrent nasopharyngeal carcinoma patients: a dose-volume-outcome analysis.
    Ni MS; Kong FF; Pan GS; Du CR; Zhai RP; Hu CS; Ying HM
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1425-1434. PubMed ID: 37995006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.